Neuroone Historical Balance Sheet

NMTC Stock

USD 0.76 0.02 2.70%

Trend analysis of Neuroone Medical Technologies balance sheet accounts such as Other Current Liab of 1.2 M provides information on Neuroone Medical's total assets, liabilities, and equity, which is the actual value of Neuroone Medical Tec to its prevalent stockholders. By breaking down trends over time using Neuroone Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Neuroone Medical Tec latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neuroone Medical Tec is a good buy for the upcoming year.

Neuroone Medical Inventory

2.77 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Neuroone Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Neuroone Medical Tec at a specified time, usually calculated after every quarter, six months, or one year. Neuroone Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Neuroone Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Neuroone currently owns. An asset can also be divided into two categories, current and non-current.

Neuroone Medical Balance Sheet Chart

At present, Neuroone Medical's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.2 M, whereas Total Assets are forecasted to decline to about 3 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab Non Current Assets Total

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Neuroone Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Neuroone Medical Tec books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Neuroone Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Neuroone Medical Tec current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	202.9K	184.4K	260.2K	400.8K
Total Assets	12.8M	8.1M	5.4M	3.0M

Short Long Term Debt Total Total Assets

Neuroone Medical balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Total Liab	Total Current Assets	Common Stock	Other Stockholder Equity	Short Term Debt	Current Deferred Revenue	Accounts Payable	Other Liab	Net Tangible Assets	Intangible Assets	Net Invested Capital	Net Working Capital	Capital Stock	Property Plant And Equipment Net
Common Stock Shares Outstanding		0.61	-0.13	0.64	0.37	0.48	-0.46	-0.96	0.47	0.47	0.86	0.67	0.65	0.6	0.9	0.95	-0.25	-0.11	0.61	0.39	0.93	-0.48	0.56	0.7	0.73	0.87
Total Assets	0.61		-0.07	0.41	0.55	0.91	-0.94	-0.75	0.96	0.97	0.78	0.04	0.41	1.0	0.56	0.78	-0.15	0.29	0.66	0.48	0.75	-0.26	0.98	0.98	0.67	0.85
Short Long Term Debt Total	-0.13	-0.07		0.61	0.74	-0.41	0.24	0.01	-0.04	-0.06	0.13	0.39	0.61	-0.09	0.14	-0.05	0.98	0.55	0.33	0.43	-0.29	0.7	-0.04	-0.03	0.0	-0.06
Other Current Liab	0.64	0.41	0.61		0.83	0.05	-0.15	-0.69	0.31	0.29	0.67	0.77	0.94	0.38	0.69	0.65	0.54	0.39	0.6	0.66	0.45	0.18	0.37	0.48	0.51	0.59
Total Current Liabilities	0.37	0.55	0.74	0.83		0.17	-0.3	-0.51	0.48	0.5	0.58	0.47	0.86	0.54	0.5	0.48	0.7	0.7	0.67	0.66	0.27	0.34	0.51	0.54	0.36	0.49
Total Stockholder Equity	0.48	0.91	-0.41	0.05	0.17		-0.98	-0.58	0.92	0.92	0.61	-0.25	0.03	0.91	0.37	0.64	-0.47	0.04	0.43	0.23	0.71	-0.41	0.92	0.88	0.56	0.71
Net Debt	-0.46	-0.94	0.24	-0.15	-0.3	-0.98		0.61	-0.97	-0.96	-0.67	0.19	-0.13	-0.95	-0.4	-0.66	0.32	-0.12	-0.53	-0.35	-0.68	0.29	-0.97	-0.93	-0.63	-0.74
Retained Earnings	-0.96	-0.75	0.01	-0.69	-0.51	-0.58	0.61		-0.64	-0.61	-0.96	-0.59	-0.68	-0.73	-0.94	-1.0	0.13	0.05	-0.76	-0.52	-0.93	0.37	-0.72	-0.83	-0.84	-0.96
Cash	0.47	0.96	-0.04	0.31	0.48	0.92	-0.97	-0.64		0.98	0.73	-0.1	0.3	0.96	0.45	0.68	-0.12	0.26	0.56	0.44	0.66	-0.16	0.99	0.95	0.66	0.77
Cash And Short Term Investments	0.47	0.97	-0.06	0.29	0.5	0.92	-0.96	-0.61	0.98		0.69	-0.1	0.31	0.97	0.42	0.66	-0.13	0.36	0.56	0.41	0.65	-0.16	0.98	0.94	0.57	0.72
Common Stock Total Equity	0.86	0.78	0.13	0.67	0.58	0.61	-0.67	-0.96	0.73	0.69		0.54	0.69	0.77	0.92	0.96	-0.01	-0.01	0.82	0.57	0.86	-0.24	0.78	0.88	0.88	0.94
Non Current Liabilities Total	0.67	0.04	0.39	0.77	0.47	-0.25	0.19	-0.59	-0.1	-0.1	0.54		0.82	0.02	0.69	0.54	0.29	0.03	0.5	0.45	0.4	0.04	-0.02	0.16	0.42	0.38
Total Liab	0.65	0.41	0.61	0.94	0.86	0.03	-0.13	-0.68	0.3	0.31	0.69	0.82		0.39	0.72	0.64	0.53	0.46	0.61	0.63	0.46	0.18	0.35	0.47	0.47	0.57
Total Current Assets	0.6	1.0	-0.09	0.38	0.54	0.91	-0.95	-0.73	0.96	0.97	0.77	0.02	0.39		0.54	0.77	-0.16	0.3	0.64	0.46	0.75	-0.27	0.98	0.97	0.65	0.83
Common Stock	0.9	0.56	0.14	0.69	0.5	0.37	-0.4	-0.94	0.45	0.42	0.92	0.69	0.72	0.54		0.92	0.0	-0.12	0.76	0.42	0.84	-0.32	0.55	0.68	0.75	0.87
Other Stockholder Equity	0.95	0.78	-0.05	0.65	0.48	0.64	-0.66	-1.0	0.68	0.66	0.96	0.54	0.64	0.77	0.92		-0.18	-0.05	0.74	0.5	0.95	-0.39	0.76	0.86	0.83	0.96
Short Term Debt	-0.25	-0.15	0.98	0.54	0.7	-0.47	0.32	0.13	-0.12	-0.13	-0.01	0.29	0.53	-0.16	0.0	-0.18		0.6	0.2	0.36	-0.41	0.73	-0.12	-0.14	-0.12	-0.17
Current Deferred Revenue	-0.11	0.29	0.55	0.39	0.7	0.04	-0.12	0.05	0.26	0.36	-0.01	0.03	0.46	0.3	-0.12	-0.05	0.6		0.12	0.23	-0.13	0.43	0.24	0.19	-0.22	-0.05
Accounts Payable	0.61	0.66	0.33	0.6	0.67	0.43	-0.53	-0.76	0.56	0.56	0.82	0.5	0.61	0.64	0.76	0.74	0.2	0.12		0.6	0.6	-0.04	0.65	0.73	0.64	0.69
Other Liab	0.39	0.48	0.43	0.66	0.66	0.23	-0.35	-0.52	0.44	0.41	0.57	0.45	0.63	0.46	0.42	0.5	0.36	0.23	0.6		0.22	0.42	0.45	0.5	0.48	0.5
Net Tangible Assets	0.93	0.75	-0.29	0.45	0.27	0.71	-0.68	-0.93	0.66	0.65	0.86	0.4	0.46	0.75	0.84	0.95	-0.41	-0.13	0.6	0.22		-0.61	0.73	0.83	0.77	0.91
Intangible Assets	-0.48	-0.26	0.7	0.18	0.34	-0.41	0.29	0.37	-0.16	-0.16	-0.24	0.04	0.18	-0.27	-0.32	-0.39	0.73	0.43	-0.04	0.42	-0.61		-0.22	-0.27	-0.28	-0.4
Net Invested Capital	0.56	0.98	-0.04	0.37	0.51	0.92	-0.97	-0.72	0.99	0.98	0.78	-0.02	0.35	0.98	0.55	0.76	-0.12	0.24	0.65	0.45	0.73	-0.22		0.98	0.69	0.83
Net Working Capital	0.7	0.98	-0.03	0.48	0.54	0.88	-0.93	-0.83	0.95	0.94	0.88	0.16	0.47	0.97	0.68	0.86	-0.14	0.19	0.73	0.5	0.83	-0.27	0.98		0.77	0.9
Capital Stock	0.73	0.67	0.0	0.51	0.36	0.56	-0.63	-0.84	0.66	0.57	0.88	0.42	0.47	0.65	0.75	0.83	-0.12	-0.22	0.64	0.48	0.77	-0.28	0.69	0.77		0.87
Property Plant And Equipment Net	0.87	0.85	-0.06	0.59	0.49	0.71	-0.74	-0.96	0.77	0.72	0.94	0.38	0.57	0.83	0.87	0.96	-0.17	-0.05	0.69	0.5	0.91	-0.4	0.83	0.9	0.87

Click cells to compare fundamentals

Neuroone Medical Account Relationship Matchups

Neuroone Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	5.4M	10.7M	16.0M	18.1M	26.8M	28.1M
Total Assets	4.8M	7.9M	12.8M	8.1M	5.4M	3.0M
Other Current Liab	454.9K	531.5K	632.5K	978.4K	1.1M	1.2M
Total Current Liabilities	2.4M	1.2M	3.1M	1.8M	2.2M	1.3M
Total Stockholder Equity	2.1M	6.6M	9.6M	6.2M	822.0K	1.5M
Net Debt	(2.7M)	(6.6M)	(8.0M)	(5.1M)	(1.2M)	(1.3M)
Retained Earnings	(30.9M)	(40.8M)	(50.8M)	(62.7M)	(75.0M)	(71.3M)
Cash	4.0M	6.9M	8.2M	5.3M	1.5M	2.0M
Cash And Short Term Investments	4.0M	6.9M	11.1M	5.3M	1.5M	2.3M
Liabilities And Stockholders Equity	4.8M	7.9M	12.8M	8.1M	5.4M	3.0M
Non Current Liabilities Total	337.7K	202.9K	119.6K	55.3K	2.3M	2.5M
Total Liab	2.7M	1.4M	3.2M	1.8M	4.5M	4.8M
Total Current Assets	4.2M	7.3M	12.2M	7.3M	4.6M	2.7M
Common Stock	22.2K	12.0K	16.2K	23.9K	30.8K	32.4K
Other Stockholder Equity	32.9M	47.4M	60.4M	68.9M	75.8M	79.6M
Accounts Payable	762.5K	528.8K	927.7K	685.1K	1.0M	535.1K
Net Tangible Assets	(1.4M)	1.9M	6.4M	9.5M	10.9M	11.5M
Non Current Assets Total	604.8K	646.5K	646.8K	784.4K	739.0K	445.5K
Non Currrent Assets Other	200.1K	230.9K	156.5K	(784.4K)	(706.0K)	(670.7K)
Other Current Assets	118.6K	244.0K	296.6K	263.7K	359.1K	377.0K
Intangible Assets	156.5K	134.2K	111.9K	89.6K	67.3K	113.3K
Property Plant Equipment	52.0K	448.2K	512.3K	535.0K	615.2K	646.0K
Net Invested Capital	3.1M	6.6M	9.6M	6.2M	822.0K	780.9K
Net Working Capital	1.8M	6.1M	9.1M	5.5M	2.4M	2.2M
Capital Stock	22.2K	35.8K	16.2K	23.9K	30.8K	23.9K
Property Plant And Equipment Net	448.2K	512.3K	535.0K	694.8K	671.8K	534.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:

How To Invest In Neuroone

Details

Is Neuroone Stock a good investment?

Details

What is Neuroone Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.46)

Revenue Per Share

0.158

Quarterly Revenue Growth

0.311

Return On Assets

(1.43)

Return On Equity

(3.49)

The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neuroone Historical Balance Sheet

Neuroone Medical Inventory

2.77 Million

About Neuroone Balance Sheet Analysis

Neuroone Medical Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Non Current Assets Total

Neuroone Medical balance sheet Correlations

Neuroone Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neuroone Medical balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 0.99	Cash
Net Invested Capital	+ 0.98	Total Assets
Net Working Capital	+ 0.98	Total Assets
Short Term Debt	+ 0.98	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.98	Cash

Other Stockholder Equity	- 1.0	Retained Earnings
Net Debt	- 0.98	Total Stockholder Equity
Net Invested Capital	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Property Plant And Equipment Net	- 0.96	Retained Earnings
Common Stock Total Equity	- 0.96	Retained Earnings